Lymphoma p53 Hotspot Mutation Cell Line Panel Item ID: ATCTCP2050
| Permits and Restrictions |
View Permits |
|---|---|
| Organism | Homo sapiens, human |
| Components | EB-3, ATCC CCL-85 CA46, ATCC CRL-1648 Namalwa, ATCC CRL-1432 DB, ATCC CRL-2289 SUP-T1, ATCC CRL-1942 |
| Applications | Biological understanding of top genetic alterations in lymphoma Novel anti-cancer drug targeting Reactivation of mutant p53 Studies related to p53 molecular mechanisms Testing small molecules or biologics for cancer drug development |
| Biosafety Level |
2 [Cells contain herpes virus]
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments |
The Lymphoma p53 Hotspot Mutation Cell Panel is comprised of five select suspension cell lines derived from lymphomas. Mutations have been sequenced and validated by ATCC. This panel includes a cell line with WT p53 as well as cell lines with p53 hotspot mutations at codons 248 and 273 |
| Product Format | 5 cryopreserved cell lines |
| Storage Conditions | liquid nitrogen vapor phase |
| Permits |
These permits may be required for shipping this product to Australia:
|
|---|---|
| Basic Documentation | Product Sheet Certificate of Analysis SDS |
| Other Documentation | p53 Hotspot Mutation Data |